Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit G Pandya

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
The British Journal of Dermatology|May 21, 2022
Impact of nonsegmental vitiligo on patients' health-related quality of life in the United StatesShoshana R Daniel, Kavita Gandhi, Kathryn P Anastassopoulos, et al.
JAMA Dermatology|November 17, 2021
Prevalence of Vitiligo Among Adults in the United StatesKavita Gandhi, Khaled Ezzedine, Kathryn P Anastassopoulos, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
Prevalence of Vitiligo among Children and Adolescents in the United StatesReema Patel, Amit G Pandya, Vanja Sikirica, et al.
The American Journal of Dermatopathology|September 17, 2009
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% creamJag Bhawan, Pearl Grimes, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|June 5, 2021
Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trialIltefat Hamzavi, David Rosmarin, John E Harris, et al.
Journal of the American Academy of Dermatology|February 21, 2017
The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligoTasneem F Mohammad, Mohammed Al-Jamal, Iltefat H Hamzavi, et al.
JAMA Dermatology|May 6, 2026
Clinical Characteristics and Treatment Patterns in Patients With VitiligoRoni Adiri, Genevieve Gauthier, Samantha K Kurosky, et al.
The Journal of Investigative Dermatology|October 1, 2016
Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of DiseaseJillian M Richmond, Dinesh S Bangari, Kingsley I Essien, et al.
The Journal of Investigative Dermatology|December 12, 2025
Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of VitiligoAmit G Pandya, Charles W Lynde, Maryam Shayesteh Alam, et al.
Lancet (London, England)|July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trialDavid Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
The British Journal of Dermatology|May 21, 2022
Impact of nonsegmental vitiligo on patients' health-related quality of life in the United StatesShoshana R Daniel, Kavita Gandhi, Kathryn P Anastassopoulos, et al.
JAMA Dermatology|November 17, 2021
Prevalence of Vitiligo Among Adults in the United StatesKavita Gandhi, Khaled Ezzedine, Kathryn P Anastassopoulos, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
Prevalence of Vitiligo among Children and Adolescents in the United StatesReema Patel, Amit G Pandya, Vanja Sikirica, et al.
The American Journal of Dermatopathology|September 17, 2009
A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% creamJag Bhawan, Pearl Grimes, Amit G Pandya, et al.
Journal of the American Academy of Dermatology|June 5, 2021
Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trialIltefat Hamzavi, David Rosmarin, John E Harris, et al.
Journal of the American Academy of Dermatology|February 21, 2017
The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligoTasneem F Mohammad, Mohammed Al-Jamal, Iltefat H Hamzavi, et al.
JAMA Dermatology|May 6, 2026
Clinical Characteristics and Treatment Patterns in Patients With VitiligoRoni Adiri, Genevieve Gauthier, Samantha K Kurosky, et al.
The Journal of Investigative Dermatology|October 1, 2016
Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of DiseaseJillian M Richmond, Dinesh S Bangari, Kingsley I Essien, et al.
The Journal of Investigative Dermatology|December 12, 2025
Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of VitiligoAmit G Pandya, Charles W Lynde, Maryam Shayesteh Alam, et al.
Lancet (London, England)|July 13, 2020
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trialDavid Rosmarin, Amit G Pandya, Mark Lebwohl, et al.
Pageof 15